Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Kilim

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Harefuah|December 15, 1994
[Human T cell lymphoma/leukemia virus type I]Y Kilim, Y L Danon
Israel Journal of Medical Sciences|December 1, 1994
Sequence analysis of the new human T cell leukemia/lymphoma virus type I isolate (HTLV-I) in IsraelY Kilim, J D Rosenblatt, Y L Danon
Annals of the New York Academy of Sciences|June 6, 1994
Molecular characterization of HTLV-I infection in IsraelY L Danon, Y Kilim, J D Rosenblatt
Leukemia Research|July 25, 1998
Molecular analysis of childhood acute lymphoblastic leukemia in IsraelO Blau, S Avigad, A Frisch, et al.
Lancet (London, England)|December 22, 1990
Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern groupD Meytes, B Schochat, H Lee, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Harefuah|December 15, 1994
[Human T cell lymphoma/leukemia virus type I]Y Kilim, Y L Danon
Israel Journal of Medical Sciences|December 1, 1994
Sequence analysis of the new human T cell leukemia/lymphoma virus type I isolate (HTLV-I) in IsraelY Kilim, J D Rosenblatt, Y L Danon
Annals of the New York Academy of Sciences|June 6, 1994
Molecular characterization of HTLV-I infection in IsraelY L Danon, Y Kilim, J D Rosenblatt
Leukemia Research|July 25, 1998
Molecular analysis of childhood acute lymphoblastic leukemia in IsraelO Blau, S Avigad, A Frisch, et al.
Lancet (London, England)|December 22, 1990
Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern groupD Meytes, B Schochat, H Lee, et al.
Pageof 1